Glycerin
Active ingredient · 2 therapeutic classes
Sold as Optase · DCH Hemorrhoidal · No More Products · Bliss GVS Children · Pranicura 5
- Drug class
- Enemas
- Availability
- Over-the-counter
- Routes
- Ophthalmic, Rectal, Transdermal, Topical
- Markets covered
- 2
- Products on record
- 33
- FDA reports (12 mo)
- 1,235
Overview
Glycerin is an active pharmaceutical ingredient in the Enemas group (A06AG). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 24 | February 10, 2026 |
| GB United Kingdom | MHRA | 9 | March 27, 2026 |
USUnited States· FDA
24 products
Uses
Uses For the temporary relief of burning and irritation due to dryness of the eye For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun For use as a protectant against further irritation or to relieve dryness of the eye
How to take
GBUnited Kingdom· MHRA
9 products
Uses
For the relief of irritating, tickling dry coughs and sore throats.
How to take
Drug interactions
Known interactions involving Glycerin. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 00071697-4ac6-49… · revised January 22, 2025 [PDF]
- [2]MHRA (UK) · PL000140307 · revised July 18, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.